Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
15/05/2025
In March, the number of building permits in Canada decreased by 4.1% compared to the previous month; it is expected to decrease by 1.2%.
Latest
5 m ago
Craig-Hallum: Maintaining Fennec Pharmaceuticals (FENC.US) rating, adjusting from Buy to Buy rating, target price adjusted from $12.00 to $13.00.
8 m ago
Craig-Hallum: Maintain rating for Biodesix (BDSX.US), adjusting from buy to hold rating, target price adjusted from $3.00 to $1.50.
10 m ago
Craig-Hallum: Maintains a buy rating for Eton Pharmaceuticals (ETON.US), adjusted from a buy rating to a buy rating, with a target price adjusted from $26.00 to $28.00.
12 m ago
HC Wainwright & Co. maintains its rating on Revolution Medicines (RVMD.US) and adjusts its recommendation from buy to buy, with a target price adjustment from $73.00 to $72.00.
12 m ago
Citigroup: Maintains a neutral rating on Lowe's Companies (LOW.US), adjusting the target price from $269.00 to $253.00.
See all latest